The detection of DNA lesions within chromatin represents a critical step in cellular responses to DNA damage. However, the regulatory mechanisms that couple chromatin sensing to DNA-damage signalling in mammalian cells are not well understood. Here we show that tyrosine phosphorylation of the protein acetyltransferase KAT5 (also known as TIP60) increases after DNA damage in a manner that promotes KAT5 binding to the histone mark H3K9me3. This triggers KAT5-mediated acetylation of the ATM kinase, promoting DNA-damage-checkpoint activation and cell survival. We also establish that chromatin alterations can themselves enhance KAT5 tyrosine phosphorylation and ATM-dependent signalling, and identify the proto-oncogene c-Abl as a mediator of this modification. These findings define KAT5 tyrosine phosphorylation as a key event in the sensing of genomic and chromatin perturbations, and highlight a key role for c-Abl in such processes.
The detection of DNA lesions within chromatin represents a critical step in cellular responses to DNA damage. However, the regulatory mechanisms that couple chromatin sensing to DNA-damage signalling in mammalian cells are not well understood. Here we show that tyrosine phosphorylation of the protein acetyltransferase KAT5 (also known as TIP60) increases after DNA damage in a manner that promotes KAT5 binding to the histone mark H3K9me3. This triggers KAT5-mediated acetylation of the ATM kinase, promoting DNA-damage-checkpoint activation and cell survival. We also establish that chromatin alterations can themselves enhance KAT5 tyrosine phosphorylation and ATM-dependent signalling, and identify the proto-oncogene c-Abl as a mediator of this modification. These findings define KAT5 tyrosine phosphorylation as a key event in the sensing of genomic and chromatin perturbations, and highlight a key role for c-Abl in such processes.
To maintain genome integrity is pivotal for cellular fitness 1 , for which sensing genomic changes represents a critical step 2 . In response to DNA double-strand breaks (DSBs) within genomic DNA, chromatin organization is altered in an orchestrated manner to facilitate the cellular DNA damage response (DDR) 3, 4 . One aspect of the DDR is checkpoint activation, which slows or halts cell-cycle progression 5 . Central to checkpoint signalling after DSBs is the serine-protein kinase ATM 6 . Although ATM is activated by its association with the MRE11-RAD50-NBS1 (MRN) complex at DSBs 7-10 , accumulating evidence suggests that ATM activity is also potentiated by mechanisms that sense chromatin alterations in the context of DNA damage 11, 12 . For example, binding of the protein lysine acetyltransferase KAT5 (also known as TIP60) to histone H3 trimethylated at lysine 9 (H3K9me3) promotes KAT5-dependent ATM acetylation, thereby enhancing ATM activity 12 . However, whether and how KAT5 binding to H3K9me3 is regulated has not been established. Here we show that the increase in KAT5 phosphorylation, mediated by the tyrosine kinase c-Abl, is involved in sensing chromatin alterations.
DNA-damage-dependent KAT5 Tyr phosphorylation
We first explored whether the KAT5-H3K9me3 interaction is regulated. Flag-tagged KAT5 was purified from cells before or after their exposure to ionizing radiation ( Fig. 1a ). As expected, we found that KAT5 bound an H3K9me3 peptide more effectively than a corresponding unmethylated peptide ( Fig. 1b ). Binding to H3K9me3 peptide was enhanced when KAT5 was purified from cells exposed to ionizing radiation ( Fig. 1b ; KAT5 failed to bind detectably to H3K4me3 and H3K27me3 peptides ( Supplementary Fig. 1 )), although this was reversed when KAT5 prepared from ionizing-radiation-treated cells was treated with l-phosphatase (l-PPase; Fig. 1b ). These findings suggest that enhanced binding of KAT5 to H3K9me3 induced by ionizing radiation depends on KAT5 phosphorylation.
As KAT5 binds H3K9me3 through its chromodomain 12 , we assessed this region for potential phosphorylation sites and identified a highly conserved residue, Tyr 44 ( Fig. 1c ). To test whether this site was phosphorylated, we expressed in human HeLa and RPE1 cells either Flag-tagged wild-type KAT5 (WT KAT5) or a derivative (YF KAT5) in which Tyr 44 was mutated to a non-phosphorylatable phenylalanine.
After mock treatment or exposure to ionizing radiation, proteins were immunoprecipitated and probed with an anti-phospho-tyrosine antibody (pY). We observed ionizing-radiation-dependent tyrosine phosphorylation of KAT5; this modification required Tyr 44, as it was not detected with YF KAT5 protein ( Fig. 1d ). Phosphorylation of both recombinant and endogenous KAT5 occurred rapidly after ionizing radiation exposure ( Fig. 1e , f). Although ionizing radiation increased the binding of WT KAT5 to H3K9me3, this was not the case for YF KAT5 protein ( Fig. 1g ).
Tyrosine phosphorylation enhances KAT5 activity
To assess the functional importance of KAT5 tyrosine phosphorylation, we examined whether mutating Tyr 44 affected the ability of an H3K9me3 peptide to stimulate KAT5-mediated ATM acetylation as detected by an acetyl-lysine (AcK) antibody 13 . An H3K9me3 peptide markedly stimulated ATM acetylation by WT KAT5 derived from ionizing-radiation-treated cells but not from non-irradiated cells ( Fig. 2a and Supplementary Fig. 2a ). By contrast, the peptide had little effect on YF KAT5 activity, irrespective of whether the protein was purified from cells exposed to ionizing radiation ( Fig. 2a ; no discernable acetyltransferase activity was observed with a catalytically inactive KAT5 derivative, KAT-I ( Supplementary Fig. 2b) ). Neither H3K9me3 peptide nor the KAT5 phosphorylation state affected the enzymatic activity of KAT5 on histone H4 ( Fig. 2a ), indicating that ionizingradiation-dependent KAT5 tyrosine phosphorylation stimulates its acetylation of ATM specifically. Next, we established complementation systems in which HeLa or RPE cell lines contained a parental vector, or vectors, stably expressing WT KAT5 or YF KAT5 derivatives that are resistant to a short-interfering RNA (siRNA) that depletes the endogenous KAT5 protein. Consistent with our biochemical findings ( Fig. 2a ), the cellular defect in ionizing-radiation-induced ATM acetylation caused by KAT5 depletion was rescued by expression of WT KAT5 but not YF KAT5 (Fig. 2b) . By contrast, both WT KAT5 and YF KAT5 proteins retained their housekeeping function, H4K16 acetylation within the p73 promoter 14 (Fig. 2c ). Consistent with the role of ATM acetylation in promoting its autophosphorylation on Ser 1981 (reported previously, see ref. 15 ), mutation of KAT5 Tyr 44 impaired ATM autophosphorylation in response to ionizing radiation (Fig. 2d ).
These data therefore indicate that ionizing-radiation-induced KAT5 tyrosine phosphorylation is required for effective ATM activation, and suggest that YF KAT5 is a separation-of-function mutant that uncouples its DDR and housekeeping roles.
Using our complementation systems, we found that, unlike cells expressing endogenous or recombinant WT KAT5, those expressing YF KAT5 did not effectively phosphorylate ATM targets CHK2 and p53 after ionizing radiation ( Fig. 2e ). Cells expressing YF KAT5 also failed to trigger an ionizing radiation-induced G1/S DNA damage checkpoint ( Fig. 2f and Supplementary Fig. 3 ; note the persistence of S phase cells in YF KAT5 compared to WT KAT5), and failed to arrest at the G2/M transition after ionizing radiation treatment (note the cells positive for the mitotic mark, histone H3 Ser-10 phosphorylation (H3S10p); Fig. 2g ). While cells depleted of endogenous KAT5 and complemented with recombinant WT protein behaved like parental cells in clonogenic survival assays, those expressing YF KAT5 were hypersensitive to ionizing radiation ( Fig. 2h ). Collectively, these findings support a model in which ionizing radiation rapidly triggers the accumulation of tyrosine-phosphorylated KAT5, thereby promoting KAT5 binding to H3K9me3 and KAT5-mediated ATM acetylation, which in turn enhances ATM activation, ATM-mediated checkpoint signalling activation and cell survival.
Chromatin alterations induce KAT5 phosphorylation
Given that DNA damage can induce chromatin reorganization 16, 17 , our finding that KAT5 tyrosine phosphorylation connects H3K9me3dependent chromatin binding to ATM activation suggests that this modification may constitute a sensing mechanism for chromatin changes. To test this idea, we altered chromatin in cells by inducing histone hyperacetylation with trichostatin A (TSA) or using siRNA-mediated depletion of heterochromatin protein 1a (HP1a; also known as chromobox protein homologue 5) to expose H3K9me3. Both TSA treatment and HP1a 
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depletion induced KAT5 tyrosine phosphorylation (Fig. 3a) , ATM acetylation ( Fig. 3b ), ATM autophosphorylation ( Supplementary Fig. 4 ) and ATM substrate phosphorylation ( Fig. 3c and Supplementary Fig. 5a ). Similarly, and consistent with a previous report 18 , the DNA-intercalating agent chloroquine induced markers of ATM signalling ( Supplementary  Fig. 5b ). Moreover, we found that these responses to TSA, HP1a depletion or chloroquine occurred with WT KAT5 but not YF KAT5 ( Fig. 3c and Supplementary Fig. 5 ). ATM acetylation after TSA treatment was prevented by KAT5 Tyr 44 mutation, thus ruling out the possibility that TSA caused ATM acetylation by inhibiting a lysine deacetylase that targets ATM (Fig. 3d ). Consistent with TSA triggering ATM activation in a manner that requires KAT5 tyrosine phosphorylation, we found that TSA caused cells to arrest in phase G1 and G2/M by mechanisms that were abrogated by KAT5 Tyr 44 mutation ( Fig. 3e and Supplementary  Fig. 6 ), or when cells were incubated with a selective ATM inhibitor (ATMi, KU-55933 (ref. 19); Fig. 3e and Supplementary Fig. 6 ). Cells expressing YF KAT5 that fail to induce cell cycle checkpoints in response to TSA treatment also displayed markedly reduced viability after acute TSA treatment (Fig. 3f) .
The above data are consistent with chromatin alterations triggering KAT5 Tyr-44-dependent, ATM-mediated checkpoint activation. However, it was possible that TSA treatment or HP1a depletion resulted in DNA damage that activated KAT5 and ATM through canonical DDR mechanisms. This scenario seems unlikely because these treatments did not cause detectable DNA breaks ( Supplementary Fig. 7 ). Furthermore, we found that siRNA-mediated depletion of MRE11, which is required for ATM activation by DSBs 7-10 , abrogated ATM activation by ionizing radiation but had little effect on ATM activation in response to TSA treatment or HP1a depletion (Fig. 3g ).
Chromatin binding fosters KAT5 phosphorylation KAT5 Tyr 44 phosphorylation rapidly accumulates after treating nonirradiated cells with the phosphatase inhibitor okadaic acid ( Fig. 4a and Supplementary Fig. 8 ; note that although okadaic acid induced ATM Ser 1981 phosphorylation at later times (3 h), it did not induce ATM acetylation). This suggests that KAT5 phosphorylation has a high turnover rate under normal conditions. We therefore speculated that this dynamic equilibrium of KAT5 phosphorylation may be altered after ionizing-radiation exposure if the phosphorylated form of KAT5 associated with perturbed chromatin, thus sequestering it from phosphatases and promoting its accumulation. Consistent with this idea, 
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addition of a methylated H3K9me3 peptide but not an unmethylated peptide protected KAT5 from dephosphorylation in vitro (Fig. 4b ). Furthermore, cellular fractionation studies revealed that, although KAT5 was present in soluble and chromatin fractions, its tyrosine-phosphorylated form induced by ionizing radiation or TSA was predominantly chromatin-associated (Fig. 4c ). In addition, coimmunoprecipitation studies revealed that, although WT KAT5 bound histone H3 and H3K9me3 in cells in an ionizing radiationinducible manner, YF KAT5 failed to do so (Fig. 4d) . Similarly, H3 bound by KAT5 was enriched for H3K36me3, another chromatin mark that simulates KAT5 activity in vitro 12 (Supplementary Fig. 9 ). Based on these observations and our finding that KAT5 binding to methylated H3 peptides impairs its dephosphorylation, we suspected that a KAT5 mutant defective in chromatin binding might fail to accumulate tyrosine phosphorylation. Indeed, a KAT5 variant bearing substitutions (F43A Y47A) in the chromodomain (CD) that abrogate H3K9me3 binding 13 (CD KAT5), displayed impaired ionizing radiation-and TSA-induced phosphorylation (Fig. 4e) . Importantly, however, CD KAT5 Tyr 44 phosphorylation still accumulated after okadaic acid treatment, indicating that the CD mutation does not affect KAT5 phosphorylation but, instead, prevents its ability to be sequestered from phosphatase action upon chromatin alterations ( Fig. 4f ; note that okadaic acid did not induce phosphorylation of YF KAT5, highlighting Tyr 44 as a prime modification site). Together, these data support a model in which increased KAT5 tyrosine phosphorylation after exposure to ionizing radiation or chromatin perturbation arises through the induction of a permissive chromatin environment that is bound by phosphorylated KAT5, thereby enhancing its half-life and accumulation.
c-Abl targets KAT5 Tyr 44 to promote ATM signalling
We reasoned that the kinase(s) mediating KAT5 Tyr 44 phosphorylation would also probably have an effect on KAT5-and ATMmediated DDR processes. Initial analyses ruled out a dependency of KAT5 phosphorylation on the DSB-responsive kinases ATM and DNA-dependent protein kinase (DNA-PK) ( Supplementary Fig.  10 ). After assessing various other potential KAT5 kinases, we focused on the tyrosine kinase c-Abl, which has been implicated previously in DDR events [20] [21] [22] [23] [24] . Pre-treating cells with the small-molecule c-Abl inhibitor imatinib 25 (Gleevec) abolished c-Abl autophosphorylation on Tyr 245 ( Fig. 5a, b ; Supplementary Fig. 11 shows antibody validation; Supplementary Fig. 12 shows that this autophosphorylation was detectable in various cell lines and was not markedly affected by ionizing radiation or TSA treatment, or by ATM or DNA-PK inhibition, and that it is predominantly nuclear). Notably, imatinib also inhibited the accumulation of KAT5 phosphorylation as well as CHK2 phosphorylation after ionizing radiation or TSA treatment (Fig. 5a, b) . Inhibition of c-Abl also prevented ionizing-radiationinduced KAT5 chromatin accumulation and H3K9me3 binding ( Supplementary Fig. 13 ). Moreover, pre-treating cells with imatinib abrogated the G1/S cell-cycle checkpoint after exposure to ionizing radiation or TSA ( Fig. 5c and Supplementary Fig. 14a ) and interfered with the induction of the G2/M checkpoint in response to ionizing radiation or TSA exposure ( Fig. 5d and Supplementary Fig. 14b ).
The finding that siRNA-mediated depletion of c-Abl also abolished the accumulation of KAT5 tyrosine phosphorylation after ionizing radiation or TSA treatment suggests that the above effects are not caused by the inhibition of other kinases by imatinib (Fig. 5e, f) . Moreover, c-Abl depletion markedly impaired the ability of ionizing radiation and TSA to trigger ATM-mediated phosphorylation of CHK2 and p53 (Fig. 5e, f and Supplementary Fig. 15a ; consistent with previous findings 22 ), and abrogated ionizing-radiation-induced checkpoint responses ( Supplementary Fig. 15b ). To assess whether these effects reflect direct targeting of KAT5 by c-Abl, we carried out in vitro kinase experiments. Thus, we found that purified c-Abl mediated tyrosine phosphorylation of purified WT KAT5 but not YF KAT5 ( Fig. 5g ; note that 22 tyrosine residues remain within YF KAT5, indicating that c-Abl is not a non-specific kinase under our assay conditions). Furthermore, pre-phosphorylation of KAT5 by c-Abl enhanced ATM acetylation by KAT5 in an H3K9me3dependent manner (Fig. 5h ).
Discussion
We have identified a mechanism involving tyrosine phosphorylation of KAT5 that underlies cellular sensing of chromatin perturbations and its coupling to checkpoint signalling. As DNA lesions result in local and global chromatin remodelling 16, 17 , this study highlights how were treated with imatinib (1 mM) for 3 h and then exposed to IR (a) or TSA treatment (b). c, Flow-cytometry analyses of RPE1 cells exposed to IR in the presence or absence of imatinib. Cells were analysed after 8 h (data: means 6 s.e.m., n 5 3). d, Cells were treated, collected 2 h post IR and analysed for H3pS10 by flow cytometry (data: mean 6 s.e.m.; n 5 3). e, f, RPE1 cells were transfected with c-Abl targeting siRNAs, and exposed to IR (e) or TSA (f), then analysed. g, In vitro kinase assays performed with recombinant c-Abl and purified Flag-KAT5 (WT KAT5 or YF KAT5). Imatinib treatment at 25 nM concentration. h, Flag-KAT5 purified from HeLa cells was bound to beads and then subjected to c-Abl-mediated phosphorylation. After washing, its activity towards ATM was assessed in the presence of K9 methylated (M) or unmethylated (U) H3 peptides.
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sensing of chromatin alterations associated with DNA lesions has a major role in promoting an effective DDR. Although the association of KAT5 with H3K9me3 may suggest that KAT5 activity would be most pronounced in heterochromatin, H3K9me3 is found within other loci 26 , and KAT5 can also be activated by H3K36me3 (ref. 12 ), which has a broad genomic distribution 27, 28 . Our data indicate that chromatin alterations can instigate checkpoint signalling independently of DNA breaks; thus, proper chromatin organization is probably monitored continuously within the cell. We have found that perturbed chromatin promotes KAT5 chromatin binding and the concurrent accumulation of KAT5 Tyr 44 phosphorylation, which in turn induces ATM-mediated signalling and checkpoint activation. These results and our findings linking c-Abl to KAT5 help to explain earlier observations of ATM activation after chromatin alterations 11, 18 . In addition, they extend previous studies linking c-Abl to DDR processes [21] [22] [23] [24] and describing functional interactions between c-Abl and KAT5 (ref. 29) .
Although our data imply that basal c-Abl kinase activity 30 is sufficient for the accumulation of tyrosine-phosphorylated KAT5 after the generation of a permissive chromatin environment, it will be of interest to see whether enhancements of c-Abl activity that have been reported to occur in response to DNA damage 20, 24 serve to potentiate ATM signalling in certain settings. It is also tempting to speculate that c-Abl-and KAT5-dependent ATM and DDR signalling may be dysregulated in progeria cells, where heterochromatin organization is perturbed [31] [32] [33] . Finally, our findings suggest new avenues for therapeutic intervention. They may explain the mode of action of certain lysine deacetylase inhibitors that are being developed as therapeutic agents 34 , and may provide insight into how such drugs can be best employed against cancer and other diseases. Our work also highlights how drugs targeting c-Abl may potentiate the effects of chromatinmodulating drugs, radiotherapy and DNA-damaging chemotherapies 35 , and may also have potential in situations in which cancer cells are particularly reliant on KAT5-and ATM-mediated signalling because they possess inherent DDR defects or are subject to ongoing DNA damage and/or chromatin perturbations.
METHODS SUMMARY
Stable cells expressing tagged KAT5 were selected in G418 (1 mg ml 21 ). For Flagbased protein purifications, cell lysates were prepared with benzonase and then high salt (450 mM) extraction. After immunoprecipitation, complexes were eluted with 33 Flag peptide. For chromatin fractionations, the soluble fraction was obtained with cytoskeleton (CSK) buffer, and subsequent to this the chromatin fraction was recovered with benzonase and then high salt extraction. Peptide binding assays were carried out as described previously 12 (see also Methods). Lysine acetyl-transferase assays were carried out as described previously 12 but with modifications as described in the Methods. Checkpoint assays involved flow cytometry on fixed cells, either by staining for DNA content alone or in combination with staining for histone H3S10p. Full methods and associated references are available in the online version of this paper.
